Drug
Bay1834845
Bay1834845: highest development phase Phase 1, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| BAY1834845 NCT03493269 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Bay1834845 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.